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Abstract
Background:  Burkholderia  cepacia strains  have  been
known to possess the capability to cause serious infec-
tions  especially  in  neonatal  intensive  care  units
(nIcus),  and  their  multi-drug  resistances  become  a
severe threat in hospital settings. the aim of this in-
vestigation was to evaluate the B. cepacia complex in-
fections in the nIcu in nagano children’s Hospital,
azumino 399-8288, Japan, and to report the interven-
tion  leading  to  the  successful  cessation  of  the  out-
break.
Methodology:  the incidence of isolation and antimi-
crobial  susceptibilities  of  nosocomial  Burkholderia
cepacia complex strains during a four-year period were
retrospectively  examined  by  clinical  microbiological
records, and by pulsed-field gel electrophoresis analy-
ses along with the bacteriological verification of disin-
fectant  device  itself  and  procedures  for  its  mainte-
nance routinely used in the nIcu.
results: during the period surveyed between 2007 and
2009, only an isolate per respective year of B. cepacia
complex  was  recovered  from  each  neonate  in  the
nIcu. However, in 2010, the successive 6 B. cepacia
complex isolates were recovered from different hospi-
talized neonates. among them, an isolate was originat-
ed from peripheral blood of a neonate, apparently giv-
ing rise to systemic infection. In addition, the hospital-
ized neonate with bacteremia due to B. cepacia com-
plex  also  exhibited  positive  cultures  from  repeated
catheterized urine samples together with tracheal aspi-
rate secretions. However other 5 isolates were consid-
ered as the transients or contaminants having little to
do with infections. Moreover, the 5 isolates between
July  and  october  in  2010  revealed  completely  the
same  electrophoresis  patterns  by  means  of  pulsed-
field  gel  electrophoresis  analyses,  strongly  indicating
that  they  were  infected  through  the  same  medical
practices, or by transmission of the same contaminant.
conclusions: a small outbreak due to B. cepacia com-
lex was brought about in the nIcu in 2010, which ap-
peared to be associated with the same genomovar of
B. cepacia complex. the source or the rout of infec-
tion was unknown in spite of the repeated epidemio-
logical investigation. It is noteworthy that no outbreak
due to B. cepacia complex was noted in the nIcu af-
ter extensive surveillance intervention.
key words: nosocomial infection, health-care-associat-
ed infection, nIcu, Burkholderia cepacia, surveillance,
disinfectant contamination
IntRoductIon.
Burkholderia cepacia complex strains are consisted of
closely  related  species  sharing  a  16S  rRna  gene  se-
quence with high similarity (>97.5%) comprising of at
least 17 validly named species and 15 genospecies [1-3],
and  have  been  increasingly  recognized  as  important
healthcare-associated infectious agents in hospitalized
and immunocompromised patients [4-6]. Strains of B.
cepacia complex are the common inhabitants found in
moist hospital environment [7, 8], reflecting its intrin-
sic  aptitude  to  survive  and  grow  in  humid  environ-
ments  with  minimal  nutrition.  Indeed,  hospital  out-
breaks have usually been due to common contaminated
sources such as disinfectant products, intravenous so-
lutions, nebulizer solutions, or medical devices [9-12].
during the routine clinical microbiological exami-
nations, we encountered successive 6 isolations of B.
cepacia complex between april and october in 2010
from different newborn babies in the neonatal inten-
sive care unit (nIcu) in nagano children’s Hospital
with 200 beds, azumino 399-8288, Japan. Emergence
of this event in 2010 led us to review the hospital’s mi-
crobiological records for B. cepacia complex coloniza-
tion or infection, during the last 4 years, that is, from
april in 2007, through october in 2010, until March in
2011.
We conducted an epidemiological investigation of
B.  cepacia complex  colonization  or  infection  in  a
neonatal intensive care unit (nIcu) of newborn-baby
ward. the newborn-baby ward is constituted of both
an nIcu with 21 beds and a growing care unit (gcu)
with 18 beds.
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cepacia complex from clinical specimens, in cases that
criteria for infection were not satisfied notwithstand-
ing  its  rate  of  isolation.  Respiratory  infections  of
neonates were defined by radiological and/or clinical
criteria, including the isolation of B. cepacia complex
from  tracheal  aspirates  (105 colony-forming  units
[cfu]/ml or more). urinary tract infections were de-
fined  by  observing  104 colony-forming  units
[cfu]/ml or more of bacterial cells. Systemic blood-
stream infections of the neonates were defined by one
or more positive blood cultures. colonization or infec-
tion was considered to be hospital-acquired when it
occurred at least 48 hours after their births in our hos-
pital. 
MEtHodS
clInIcal EPIdEMIologY analYSES
the numbers of emergence and the dates of isolation
of B. cepacia complex from the neonates in the nIcu
were inspected from april in 2007, through december
in 2010, until March in 2011, whether or not the iso-
lates were considered as causative agents, residents or
contaminants. Biochemical characterization and identi-
fication together with the antimicrobial susceptibilities
of the isolates were carried out with the MicroScan
Walkaway  40  System  (Siemens  Healthcare  diagnos-
tics, tokyo, Japan) using the neg combo 3.12J panels
(Siemens Healthcare diagnostics, tokyo, Japan) in the
system  according  to  the  manufacture’s  instructions.
commercially  available  kit  systems,  Id-test  nf18
panels  (nissui  Pharmaceuticals  co.,  ltd.,  tokyo,
Japan.) were used, when necessary, for confirmation of
biochemical properties. We then compared the isola-
tion rate during the epidemic period (between July and
october in 2010) with that ahead of the outbreak (be-
tween april in 2007 and March in 2010).
Between april and october in 2010, the different 6
neonates successively yielded positive cultures for B.
cepacia complex strains in routine clinical microbiolo-
gy laboratory examinations. among the 6 neonates, re-
cent 5 neonates with overlapping periods of hospital-
ization  was  molecular  epidemiologically  analyzed  by
means  of  pulsed-field  gel  electrophoresis  to  investi-
gate  their  genetic  relatedness  [13,  14].  Isolates  were
grown in 2 ml of Brain-Heart-Infusion (nissui Phar-
maceuticals co., ltd., tokyo, Japan.) broth media at
35ﾰc for 18 hours, and the dnas were prepared from
the bacterial pellets as previously described [15]. the
respective dna was digested with SpeI (5 -actagt-
3 ) restriction enzyme (takara Bio Inc., Shiga, Japan.),
and analyzed according to the manufacturer’s instruc-
tions. two unrelated isolates that were recovered from
the infant inpatients in other different wards were in-
cluded in the pulsed-field gel electrophoresis analyses
for comparison.
MIcRoBIologIcal REvIEW of RoutInE PRocEduRES
foR dISInfEctIon
Procedures for the use, maintenance, and disinfection
of the respiratory therapy devices in the nIcu were
observed and reviewed. the three experts consisting
of two infection control doctors (Icds) and an infec-
tion control nurse (Icn) from outside the ward con-
ducted the procedural audit. It focused on all respira-
tory manipulations, including secretion aspiration, in-
tubation, and mechanical ventilation. Special attention
was paid to the handling of disinfectant-equipments. 
during  the  epidemic  period  of  october  days  in
2010,  we  collected  all  of  the  disinfectant-containing
bottles from each hospital personnel and from envi-
ronmental sites in the nIcu. a total of 104 disinfec-
tant fluids in bottles consisting of 37 ethyl-alcoholic
solution  with  glycerin,  13  ethyl-alcoholic  chlorhexi-
dine-digluconate,  13  ethyl-alcoholic  benzalkonium-
chloride,  together  with  34  hand-washing  soap  solu-
tions and 7 lotion fluids for hand care, were properly
diluted in a ten-fold fashion, and then plated duplicate
(100  ﾵl,  respectively)  on  trypticase-Soy  agar  plates
(Eiken chemical co., ltd., tokyo, Japan.), or 1 ml of
respective undiluted disinfectant, hand-washing soap,
or lotion fluid for hand care was put into 15 ml of
Brain-Heart-Infusion  (nissui  Pharmaceuticals  co.,
ltd., tokyo, Japan.) broth media and then incubated at
35ﾰc  for  72  hours.  cotton-swab  samples  from  sur-
faces of respiratory therapy devices, infant incubators,
and  keyboards  of  personal  computers  in  the  nIcu
were spread onto Sheep Blood agar (nippon Becton
dickinson co., ltd., tokyo, Japan.) plates and incubat-
ed at 35ﾰc for 72 hours. 
In addition, we tried to verify the hand-washing
procedures by the Icn in our hospital, concerning 9
link nurses from all of the divisions consisting of 7
clinical wards including nIcu of newborn-baby ward,
1 operation room, and 1 outpatient clinic department,
and together with 50 full-time medical doctors in the
nagano children’s Hospital, by means of palm-stamp
methodsusingScdlPagar (Palm-Stamp-check) plates
(nikken Bio Medical laboratory Inc., Kyoto, Japan). a
total of 57 medical personnel were microbiologically
surveyed by the Icn for the exaltation of improving
routine  healthcare  infection  control  practices.  the
number  of  bacteria  was  counted  by  a  palm  stamp
check agar plate method for general bacteria before
and after hand-washing. 
RESultS
analYtIcal EPIdEMIologY of B. cepacia
coMPlEx ISolatIonS
as shown in figure 1, the 9 neonates (from Patient-1
to Patient-9) in the nIcu grew B. cepacia complex; of
these, as for a total of 3 neonates (i.e., Patient-1, -2,
and -3) every 1 isolate a year was recovered from nasal
secretions or tracheal aspirates as colonization or con-
tamination, between april in 2007 and March in 2010.
the remaining 6 neonates yielded B. cepacia complex
between april in 2010 and october in 2010, consid-
ered being a small outbreak.  the breakdown of the
outbreak occurred was as follows; a premature neona-
tal Patient-4 with congenital thorax disease on april 4
from nasal secretion and then on april 27 from nasal
secretion and tracheal aspirate, a chromosomal abnor-
mality neonatal Patient-5 with congenital heart disease
on  July  13  from  tracheal  aspirate,  and  a  premature
neonatal Patient-6 with extremely low birth weight on
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from both peripheral blood and catheterized urine on
September  21,  and  a  premature  neonatal  Patient-7
with respiratory distress on September 14 from tra-
cheal  aspirate,  a  pyruvate  dehydrogenase  deficient
neonatal Patient-8 with respiratory ventilation on Sep-
tember  28  from  tracheal  aspirate,  and  then  an  ex-
tremely  low-birth-weight  infant  Patient-9  with  tri-
somy-18 syndrome and with congenital diseases from
tracheal  and  nasal  secretions.  the  hospitalization  of
the latter 5 neonates (P-5, -6, -7, -8, and -9) yielding B.
cepacia complex wholly overlapped. 
MIcRoBIologIcal analYSES of EnvIRonMEntS and
PRocEduRES REvIEW
In the examination of the 5 clinical isolates from dif-
ferent 5 neonates (Patient-5, -6, -7, -8, and -9), the neg
combo 3.12J panels in the MicroScan Walkaway 40
plus system represented almost entirely the same pro-
file number (data not shown) and almost exactly the
same  antibiograms  with  one  another  as  shown  in
table 1, demonstrating that the most active agent was
meropenem (MIc-values, less than 1 ﾵg/ml) followed
by  minocycline  and  sulfisoxazol/trimethoprim  (both
MIc-values,  less  than  2  ﾵg/ml),  and  new  quinolone
drugs  of  levofloxacin  and  ciplofloxacin  (both  MIc-
values, less than 0.5 or 1 ﾵg/ml). However, the 2 iso-
lates (Patient-a and Patient-B) derived from the wards
unrelated to the nIcu for comparison revealed the
different antibiograms, as shown in table 1, that is,
both 2 displayed resistances to new quinolone drugs
of levofloxacin and ciplofloxacin (both MIc-values, 2
ﾵg/ml  or  more),  one  with  resistance  to  ceftazidime
(MIc-values, more than 16 ﾵg/ml), and the another
with resistance to minocycline (MIc-values, 4 ﾵg/ml),
in  distinctive  contrast  to  the  epidemic  isolates  from
the neonatal Patient-5, -6a, -6b, -7, -8, and -9.
Moreover, as shown in figure 2, the pulsed-field gel
electrophoresis analyses of the 6 isolates (each 1 iso-
late from Patient-5, -7, -8, and -9, and 2 isolates from
the different specimens of Patient-6 designated as Pa-
tient-6a  and  -6b)  yielded  indistinguishable  elec-
trophoresis patterns, with the two different patterns
from diverse isolates in other wards for comparison. 
no B. cepacia complex isolate was recovered from
all  of  the  medical  devices,  equipments  or  the  key-
boards  of  personal  computers.  the  later  keyboards
were overlapped with the very dedicated own covers
being  changed  three-times  a  day  for  the  disinfected
ones treated with ethyl-alcoholic disinfectants.
Repeated isolation trials failed to detect B. cepacia
complex  from  any  of  the  104  disinfectant  fluids  in
bottle devices that the personnel in the nIcu always
wearing  around  their  own  waists,  and  that  already
arranged in the appropriate sites in the ward. 
Microbiological  verification  of  hand-washing  pro-
cedures by hospital personnel in the nIcu was per-
formed  with  the  palm-stamp  methods.  It  should  be
noticeable that no growth of colonies indicative of B.
cepacia complex  occurred  and  that  the  obvious  de-
crease of general bacterial cell counts was manifested
almost all the personnel investigated, after their usual
hand-washing procedures using any of the hand-wash-
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medical doctors. that is, 9 out of 57 hospital person-
nel surveyed had to attend the lectures on hand-wash-
ings and on hygiene, and then they were to be further
rechecked  the  processing  of  hand-washings  by  the
Icn.
dIScuSSIon
Burkholderia cepacia complex strains are problematic
pathogens  in  the  hospital  settings  because  of  their
high  resistances  to  antimicrobials,  of  making  infec-
tions difficult to treat, and of their innate potentials to
survive  or  inhabit  in  every  moist  hospital  environ-
ment. Moreover, they are difficult to identify and addi-
tional new species have now been found to constitute
isolates  originally  identified  as  B.  cepacia complex
based on their phenotypic properties [1-3]. Indeed, the
taxonomy  of  the  B.  cepacia complex  has  advanced
considerably along with the molecular biological devel-
opment  for  their  accurate  identification  to  the
genospecies level [3]).
as shown in figure 1, during the period between
april  in  2007  and  March  in  2010,  the  3  B.  cepacia
complex isolates from 3 different neonates (Patients-1,
-2, and -3) were recovered in the nIcu from the clini-
cal specimens; Patient-1 from nasal secretion in 2007
and Patients-2 and -3 from tracheal aspirates both at a
density of less than 103 cfu/ml in 2008 and 2009,
respectively)  with  no  clinical  sigh  of  infections,  and
therefore every B. cepacia complex isolate was consid-
ered  as  a  transient  contaminant.  In  the  subsequent
analyses during the period between april and october
in 2010, the 5 (Patients-4, -5, -7, -8 and -9) out of the
6 neonates yielding B.  cepacia complex isolates were
born in our hospital and successively hospitalized in
the nIcu during the overlapping periods. the resid-
ual 1 neonatal Patient-8 was promptly hospitalized in
the nIcu in our hospital soon after being transported
from different hospital.
that is to say, all of the 9 acquisitions of B. cepacia
complex were diagnosed as hospital-acquired. In par-
ticular, all of the 5 neonates (P-5, -6, -7, -8, and -9)
yielding B. cepacia complex isolates between Septem-
ber and october in 2010 had been hospitalized in the
nIcu during the absolutely overlapping periods, rais-
ing the possibility of neonate-to-medical personnel or
–medical equipments-to-neonate transmission. 
therefore we discriminate the 5 epidemic isolates
by means of pulsed-field gel electrophoresis analyses,
and  found  that  all  of  the  5  isolates  exhibited  com-
pletely  identical  electrophoresis  patterns,  as  clearly
demonstrated in figure 2, indicating that they should
be the causative agents of healthcare-associated infec-
tions or transmissions during the overlapping periods
due to the same contaminant origin in the nIcu.  B.
cepacia complex strains are easily transmitted from pa-
tient to patient through close contact or through envi-
ronmental acquisition [16, 17]. In order to prevent the
transmission, important aspects concern the disinfec-
tant equipments, because B.  cepacia complex strains
may contaminate the devices and may survive by re-
sisting against the disinfectant fluids [18]. therefore
we made sure by microbiologically checking whether
the disinfectant fluids were contaminated with B. cepa-
cia complex or not. the disinfectant devices are not
only  placed  in  predefined  positional  places  but  also
carried  all  the  time  by  respective  personnel  in  the
nIcu with their waists and are always utilized in cases
disinfection was needed. We microbiologically exam-
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Fig. 1. time course of Burkholderia cepacia complex outbreak in the neonatal intensive care unit (nIcu) from april in 2007
through october in 2010 to March in 2011. Each bar represents the hospitalization period of each inpatient neonate. See table
1, for the origins, and see text in the Results section, for the backgrounds of the isolates. 
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disinfectant devices in the nIcu, however, no isola-
tion of B.  cepacia complex was observed even after
the repeated investigation trials. It should be challeng-
ing and difficult to find out the origin, source or the
rout of infection with B. cepacia complex.
although  the  examinations  for  general  bacterial
counts before and after the hand-washing was indeed
useless to clarify the origin or the rout of infections
due to B. cepacia complex, it should be noted that the
hand-washing is fundamentally basic and imperative in
controlling  healthcare-associated  infections  or  trans-
missions. Moreover, we should anticipate that full-time
medical doctors as well as link nurses would play an
important role in their own clinical area to facilitate li-
aison with the colleagues and other surrounding med-
ical  personnel  in  routine  infection  control  practices
[19, 20]. 
no  environmental  source  or  no  obvious  mecha-
nism  of  transmission  of  B.  cepacia complex  was
found in the nIcu of newborn ward. However, since
october in 2010 when these microbiological examina-
tions had been carried out in the nIcu, what is note-
worthy is no new cases of colonization or infection
with B. cepacia complex have occurred for the last 5
months,  despite  the  presence  of  neonatal  inpatients
colonized with B. cepacia complex on the ward. this
led us to consider that the reinforcement of, or step-
ping into hygienic measures should give the deterrent
effect against the spread of the infections.
this study illustrates a value of careful epidemio-
logic investigation in controlling the colonization or
infections due to B. cepacia complex. complete elimi-
nation of the transmission among the neonates was
achieved  only  after  the  intervention  of  investigating
microbiologically the environmental sites in the nIcu,
particularly  the  104  disinfectant  devices  that  every
medical personnel in the nIcu always bring in each
hip pouch around each waist. these active microbio-
logical interventions might actually lead to the cessa-
tion of the outbreak, despite the fact that the source
or the rout of infection due to B. cepacia complex in
the nIcu was not found. 
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Fig. 2. Profiles of the genomic dnas of 6 epidemic Burkholderia cepacia complex after digestion with SpeI (5 -actagt-3 )
restricted enzyme in the neonatal intensive care unit, together with 2 Burkholderia cepacia complex isolates in different wards,
for comparison.
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